细胞因子在类风湿性关节炎中起作用的证据。
Evidence that cytokines play a role in rheumatoid arthritis.
作者信息
Brennan Fionula M, McInnes Iain B
机构信息
Kennedy Institute of Rheumatology, Imperial College London, London, UK.
出版信息
J Clin Invest. 2008 Nov;118(11):3537-45. doi: 10.1172/JCI36389.
Abstract
A large number of cytokines are active in the joints of patients with rheumatoid arthritis (RA). It is now clear that these cytokines play a fundamental role in the processes that cause inflammation, articular destruction, and the comorbidities associated with RA. Following the success of TNF-alpha blockade as a treatment for RA, other cytokines now offer alternative targets for therapeutic intervention or might be useful as predictive biomarkers of disease. In this Review, we discuss the biologic contribution and therapeutic potential of the major cytokine families to RA pathology, focusing on molecules contained within the TNF-alpha, IL-1, IL-6, IL-23, and IL-2 families.
摘要
大量细胞因子在类风湿关节炎（RA）患者的关节中具有活性。现在已经明确，这些细胞因子在引发炎症、关节破坏以及与RA相关的合并症的过程中发挥着根本性作用。随着肿瘤坏死因子-α（TNF-α）阻断剂作为RA治疗方法取得成功，其他细胞因子如今为治疗干预提供了替代靶点，或者可能用作疾病的预测生物标志物。在本综述中，我们讨论了主要细胞因子家族对RA病理的生物学贡献和治疗潜力，重点关注TNF-α、白细胞介素-1（IL-1）、白细胞介素-6（IL-6）、白细胞介素-23（IL-23）和白细胞介素-2（IL-2）家族中的分子。
相似文献
1
Evidence that cytokines play a role in rheumatoid arthritis.细胞因子在类风湿性关节炎中起作用的证据。
J Clin Invest. 2008 Nov;118(11):3537-45. doi: 10.1172/JCI36389.
2
Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.肥大细胞活化及其与类风湿性病变中促炎细胞因子产生的关系。
Arthritis Res. 2000;2(1):65-74. doi: 10.1186/ar70.
3
Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs.促炎细胞因子协同增强类风湿性成纤维样滑膜细胞体外产生趋化因子配体 20（CCL20），而生物改善病情抗风湿药物在体内降低血清 CCL20。
J Rheumatol. 2009 Nov;36(11):2397-402. doi: 10.3899/jrheum.090132. Epub 2009 Oct 1.
4
Embracing novel cytokines in RA - complexity grows as does opportunity!拥抱 RA 中的新型细胞因子——复杂性增加，机会也随之增加！
Best Pract Res Clin Rheumatol. 2010 Aug;24(4):479-87. doi: 10.1016/j.berh.2010.01.004.
5
Joint inflammation and cytokine inhibition in rheumatoid arthritis.类风湿关节炎中的关节炎症与细胞因子抑制
Clin Exp Med. 2006 Mar;6(1):13-9. doi: 10.1007/s10238-006-0088-5.
6
7
Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy.分析 SF 和血浆细胞因子可深入了解炎症性关节炎的发病机制，并可能预测对治疗的反应。
Rheumatology (Oxford). 2012 Mar;51(3):451-9. doi: 10.1093/rheumatology/ker338. Epub 2011 Dec 16.
8
[Cytokines in rheumatoid arthritis].[类风湿关节炎中的细胞因子]
Postepy Hig Med Dosw. 1997;51(6):621-36.
9
TNF alpha as a therapeutic target in rheumatoid arthritis.肿瘤坏死因子α作为类风湿关节炎的治疗靶点。
Circ Shock. 1994 Aug;43(4):179-84.
10
New therapies for rheumatoid arthritis.类风湿关节炎的新疗法。
Clin Exp Immunol. 2005 May;140(2):195-204. doi: 10.1111/j.1365-2249.2005.02744.x.
引用本文的文献
1
NLRP3 inflammasome impairs fracture repair in Rheumatoid arthritis through RhoA/Rac1-IL1β axis-mediated suppression of osteoblast differentiation.NLRP3炎性小体通过RhoA/Rac1-IL1β轴介导的对成骨细胞分化的抑制作用损害类风湿性关节炎中的骨折修复。
J Orthop Translat. 2025 Aug 9;54:152-166. doi: 10.1016/j.jot.2025.07.012. eCollection 2025 Sep.
2
The RNA-binding protein RRP1 brakes macrophage one-carbon metabolism to suppress autoinflammation.RNA结合蛋白RRP1抑制巨噬细胞一碳代谢以抑制自身炎症。
Nat Commun. 2025 Jul 25;16(1):6880. doi: 10.1038/s41467-025-62173-3.
3
Female Mice Lacking LSD1 in Myeloid Cells Are Resistant to Inflammatory Bone Loss.骨髓细胞中缺乏LSD1的雌性小鼠对炎性骨质流失具有抗性。
Cells. 2025 Jul 19;14(14):1111. doi: 10.3390/cells14141111.
4
Microneedle-based sustained release delivery of TNF-α/IL-6R dual-specific fenobody alleviates inflammation and promotes bone regeneration in rheumatoid arthritis rat model.基于微针的肿瘤坏死因子-α/白细胞介素-6受体双特异性融合蛋白持续释放递送可减轻类风湿性关节炎大鼠模型的炎症并促进骨再生
Mater Today Bio. 2025 May 30;33:101905. doi: 10.1016/j.mtbio.2025.101905. eCollection 2025 Aug.
5
Immunoinflammatory evidence of rheumatoid arthritis caused by COVID-19.由新冠病毒引起的类风湿性关节炎的免疫炎症证据。
Biol Res. 2025 Jun 10;58(1):38. doi: 10.1186/s40659-025-00620-7.
6
Preconditioning of bone marrow mesenchymal stem cells with sodium hydrosulfide enhances their therapeutic potential in type II collagen-induced arthritis rat model.用硫氢化钠对骨髓间充质干细胞进行预处理可增强其在II型胶原诱导的关节炎大鼠模型中的治疗潜力。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 14. doi: 10.1007/s00210-025-04222-8.
7
From Joints to the Heart: An Integrated Perspective on Systemic Inflammation.从关节到心脏：系统性炎症的综合视角
Life (Basel). 2025 Apr 9;15(4):629. doi: 10.3390/life15040629.
8
Preclinical assessment of anti-arthritic activity of methanolic extract from processed Plumbago zeylanica roots.加工过的白花丹根甲醇提取物抗关节炎活性的临床前评估
Sci Rep. 2025 Apr 3;15(1):11454. doi: 10.1038/s41598-025-95744-x.
9
Healthy and premature aging of monocytes and macrophages.单核细胞和巨噬细胞的健康衰老与过早衰老。
Front Immunol. 2025 Mar 17;16:1506165. doi: 10.3389/fimmu.2025.1506165. eCollection 2025.
10
TNFR-LSTM: A Deep Intelligent Model for Identification of Tumour Necroses Factor Receptor (TNFR) Activity.TNFR-LSTM：一种用于识别肿瘤坏死因子受体（TNFR）活性的深度智能模型。
IET Syst Biol. 2025 Jan-Dec;19(1):e70007. doi: 10.1049/syb2.70007.
本文引用的文献
1
IL-33 exacerbates antigen-induced arthritis by activating mast cells.白细胞介素-33通过激活肥大细胞加重抗原诱导的关节炎。
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10913-8. doi: 10.1073/pnas.0801898105. Epub 2008 Jul 30.
2
Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.中和白细胞介素-21和白细胞介素-15可抑制类风湿性关节炎中促炎细胞因子的产生。
Scand J Immunol. 2008 Jul;68(1):103-11. doi: 10.1111/j.1365-3083.2008.02118.x. Epub 2008 May 9.
3
IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.IL-21和转化生长因子-β是人类辅助性T细胞17（Th17）分化所必需的。
Nature. 2008 Jul 17;454(7202):350-2. doi: 10.1038/nature07021. Epub 2008 May 11.
4
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.地诺单抗对类风湿关节炎结构损伤、骨密度和骨转换的治疗效果：一项为期十二个月的多中心、随机、双盲、安慰剂对照的II期临床试验。
Arthritis Rheum. 2008 May;58(5):1299-309. doi: 10.1002/art.23417.
5
The biological functions of T helper 17 cell effector cytokines in inflammation.辅助性T细胞17效应细胞因子在炎症中的生物学功能
Immunity. 2008 Apr;28(4):454-67. doi: 10.1016/j.immuni.2008.03.004.
6
Th17 cell differentiation: the long and winding road.辅助性T细胞17分化：漫长而曲折的道路
Immunity. 2008 Apr;28(4):445-53. doi: 10.1016/j.immuni.2008.03.001.
7
Lymphocyte-derived cytokines in inflammatory arthritis.炎症性关节炎中淋巴细胞衍生的细胞因子
Autoimmunity. 2008 Apr;41(3):230-8. doi: 10.1080/08916930701694766.
8
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.托珠单抗治疗全身型幼年特发性关节炎患者的疗效和安全性：一项随机、双盲、安慰剂对照、撤药期III期试验
Lancet. 2008 Mar 22;371(9617):998-1006. doi: 10.1016/S0140-6736(08)60454-7.
9
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.托珠单抗抑制白细胞介素-6受体对类风湿关节炎患者的影响（OPTION研究）：一项双盲、安慰剂对照的随机试验。
Lancet. 2008 Mar 22;371(9617):987-97. doi: 10.1016/S0140-6736(08)60453-5.
10
Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers.产生白细胞介素-17的T细胞在患有关节炎的儿童关节中富集，但与调节性T细胞数量呈反比关系。
Arthritis Rheum. 2008 Mar;58(3):875-87. doi: 10.1002/art.23291.
Zotero 插件